Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 352 entries
View as:

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs

Phase: N/A Priority: Normal
NCT ID: NCT01387594 Org: User:
Start: 05/03/12 End: 11/26/15 Due: 11/26/16

A Study of VPRIV in Participants With Gaucher Disease Previously Treated With Other Enzyme Replacement Therapies or Substrate Reduction Therapies

Phase: N/A Priority: Normal
NCT ID: NCT04094181 Org: User:
Start: 09/19/19 End: 11/17/21 Due: 11/17/22

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Phase: N/A Priority: Normal
NCT ID: NCT02586805 Org: User:
Start: 03/03/16 End: 04/13/17 Due: 04/13/18

The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00928148 Org: User:
Start: 06/14/04 End: 11/20/04 Due: 11/20/05

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Phase: N/A Priority: Normal
NCT ID: NCT01756157 Org: User:
Start: 02/04/13 End: 09/13/13 Due: 09/13/14

Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17

Phase: N/A Priority: Normal
NCT ID: NCT00152009 Org: User:
Start: 01/29/03 End: 08/23/03 Due: 08/23/04

Prevention of Recurrence of Diverticulitis

Phase: N/A Priority: Normal
NCT ID: NCT00545740 Org: User:
Start: 11/28/07 End: 03/05/12 Due: 03/05/13

Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/Mesalamine

Phase: N/A Priority: Normal
NCT ID: NCT01469637 Org: User:
Start: 11/07/11 End: 12/20/11 Due: 12/20/12

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multiple Doses of SHP681 (Glucagon-like Peptide-2 [GLP-2] Analog-Fc Fusion) in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT03859323 Org: User:
Start: 03/26/19 End: 01/06/20 Due: 01/06/21

Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)

Phase: N/A Priority: Normal
NCT ID: NCT03582449 Org: User:
Start: 01/19/18 End: 05/10/20 Due: 05/10/21

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Phase: N/A Priority: Normal
NCT ID: NCT01518946 Org: User:
Start: 05/14/12 End: 06/22/13 Due: 06/22/14

A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)

Phase: N/A Priority: Normal
NCT ID: NCT03324880 Org: User:
Start: 01/24/18 End: 05/19/22 Due: 05/19/23

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

Phase: N/A Priority: Normal
NCT ID: NCT01707667 Org: User:
Start: 02/27/13 End: 11/27/13 Due: 11/27/14

Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17

Phase: N/A Priority: Normal
NCT ID: NCT00150618 Org: User:
Start: 03/30/04 End: 10/07/04 Due: 10/07/05

An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis Access

Phase: N/A Priority: Normal
NCT ID: NCT01806584 Org: User:
Start: 03/28/13 End: 10/23/14 Due: 10/23/15

Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01130831 Org: User:
Start: 04/26/10 End: 06/12/12 Due: 06/12/13

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Phase: N/A Priority: Normal
NCT ID: NCT00438815 Org: User:
Start: 09/21/06 End: 03/31/09 Due: 03/31/10

A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®

Phase: N/A Priority: Normal
NCT ID: NCT00920647 Org: User:
Start: 11/18/09 End: 10/29/12 Due: 10/29/13

Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17

Phase: N/A Priority: Normal
NCT ID: NCT00150592 Org: User:
Start: 05/12/05 End: 10/05/05 Due: 10/05/06

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00500071 Org: User:
Start: 06/28/07 End: 01/02/08 Due: 01/02/09

Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01457339 Org: User:
Start: 10/21/11 End: 01/20/12 Due: 01/20/13

Open Label Extension

Phase: N/A Priority: Normal
NCT ID: NCT00172120 Org: User:
Start: 01/10/05 End: 10/27/06 Due: 10/27/07

A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302

Phase: N/A Priority: Normal
NCT ID: NCT03268811 Org: User:
Start: 08/23/17 End: 11/02/21 Due: 11/02/22

A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations

Phase: N/A Priority: Normal
NCT ID: NCT02204579 Org: User:
Start: 07/18/14 End: 05/04/15 Due: 05/04/16

TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00172081 Org: User:
Start: 04/27/00 End: 11/07/03 Due: 11/07/04